Jiaodong Online News on June 30 (Reporter Wang Xiangrong, Correspondent Guo Jian) The pharmaceutical and health industry is one of the eight key industries in Yantai City. The high-tech zone has vertically connected R&D industrialization channels, establishing a network from R&D, incubation, manufacturing, and circulation. to the entire chain industrial system of medical services. It plans to achieve key breakthroughs in six sub-sectors: drug and vaccine field, high-end medical equipment field, cell and gene therapy field, special medical and health food field, medical, aesthetic and health care application integration field, and pharmaceutical circulation field.
R&D is the foundation for the development of the medical and health industry, and talent is the cornerstone of R&D. The China Science and Technology Bohai (Yantai) Advanced Institute of Pharmaceutical Sciences (referred to as the "Advanced Research Institute") under construction in the High-tech Zone is one of the "three major science and technology innovation platforms" focused on building in the city. It will carry out application basic and application development research on innovative drugs. , public technical services, industrial incubation and cultivation and application-oriented graduate training, create a new R&D institution with flexible mechanisms and internationally advanced new drug R&D innovation highlands, build a national high-end biomedical R&D integrated platform around the entire chain of scientific and technological innovation, and build a China’s “Northern Blue Medicine Valley” with significant international influence.
The Institute of Advanced Research is accelerating its progress, and the blue medicine valley in the north is rising.
Walking into the project construction site of the Institute of Advanced Research, the reporter saw that the "Institute of Advanced Research" animal experimental facilities and graduate student apartment projects are under construction in full swing. In the future, a large number of medical and health R&D personnel will be stationed here to continuously promote industrial development and upgrading.
The "Institute of Advanced Research" animal experimental facilities and graduate student apartment projects were launched in January 2022 and implemented by Yantai High-tech Construction Investment and Development Co., Ltd. The annual plan "completes the construction of the main structure of the animal experimental facility building and graduate student apartment building, and starts the animal experimental facilities Building decoration construction". This project will build two postgraduate dormitories, a cultural and sports activity center, teaching supporting facilities (including cultural and sports activity centers), experimental animal facilities, warehouses, underground garages and animal room facilities, totaling approximately 67,000 square meters. In order to ensure the smooth completion of the project, in the early stage of the project, the Yantai High-tech Zone Management Committee established a special project management team headed by the leaders of the management committee to reverse the construction period and work on the wall chart, follow up the project progress regularly every week, and solve the difficulties in project construction in a timely manner. Pain points and congestion points.
At present, the underground construction of the animal experimental facility building of the "Advanced Research Institute" has been completed, and the construction of the second floor above the ground is smoothly underway. The underground structure of the graduate school teaching building has been fully started, and the graduate dormitory building and other buildings are rushing to work. In the next step, the project team will start the construction of the main structure as soon as possible, complete the capping of the animal facility building in July, complete the capping of the graduate dormitory building in September, and start comprehensive decoration by the end of the year.
Build a "2+3+X" biomedical industry park layout to create an innovation highland
The high-tech zone plans to build a "2+3+X" biomedical industry park layout with clear positioning, distinctive features and complete supporting facilities, that is, with The two parks of Shandong International Biotechnology Park and Bohai Rim Pharmaceutical Advanced Research Institute are the industry chain innovation leading functional area , and the three carriers of industrialization are the Medical and Health Industrialization Base, Luye Pharmaceutical Industrial Park and Shandong Vaccine Industrialization Base. The core carrying functional area is ; accelerating the operation and production of several key project parks such as Atomy Industrial Park and Saichun Biotechnology Park.
In 2021, Yantai companies in the city have nearly 30 key pharmaceutical and device products under development that have entered the clinical stage, and companies in the High-tech Zone account for about half. At the same time, the Yantai Branch of the Shanghai Institute of Materia Medica has carried out the research and development of 27 new drugs and generic drugs, and 4 new drugs are about to enter the clinical stage. Starting with the launch of the Paino VLP vaccine project, relying on the vaccine innovation and industrialization base in Shandong Province, we will build a complete industrial chain of scientific research, production, and circulation in the field of vaccines, and quickly form an innovative vaccine industry cluster for human use. In the next five years, the High-tech Zone will enter the harvest period of innovative drug research and development, seize the five-year growth opportunities, promote industrial transformation and upgrading, and create an innovative drug highland with important domestic influence.
To improve the innovation capacity of the industrial chain, the High-Tech Zone will inject vitality from the source.
In order to improve the innovation capacity of the industrial chain, the High-tech Zone will speed up its actions.Accelerate the construction of the Bohai Rim (Yantai) Advanced Pharmaceutical Research Institute, focus on supporting R&D platforms such as the Yantai Branch of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, the Yantai Public Technology Service Platform for Medicine and Health, and the Luye Pharmaceutical R&D Center, so as to exert the scientific research empowerment effect and form a R&D innovation platform. Normalize, systematize, and scale; focus on developing the R&D service outsourcing industry relying on the Yantai Pharmaceutical and Health Public Technical Service Platform, and provide a complete set of solutions from drug R&D to marketing services. In the first half of 2021, Yantai Medicine and Health Public Technical Service Platform completed more than 6,000 external research services.
On March 25, 2022, Shandong Provincial People's Government issued the "Reply on the Construction Plan of Three Shandong Provincial Laboratories including Yantai New Drug Creation", relying on the "Yantai New Drug Creation Shandong Provincial Laboratory" built by Yantai Advanced Research Institute. It was approved for construction and became the first biomedical provincial laboratory in Shandong Province and the second Shandong provincial laboratory planned and constructed by Yantai City.
On March 29, 2022, the Bohai (Yantai) Advanced Institute of Pharmaceutical Sciences (hereinafter referred to as the "Institute") was recognized as the "Shandong Province Postdoctoral Innovation Practice Base", which marked another step in the construction of the Institute's scientific and technological innovation platform. An important breakthrough has been achieved, which is of great significance to enhancing scientific research and innovation capabilities and promoting the transformation of scientific and technological achievements.
In the next step, the Institute will use the "Yantai New Drug Creation Shandong Laboratory" and the "Shandong Postdoctoral Innovation Practice Base" as important carriers to further strengthen and improve the laboratory construction around the biomedical industry planning of Shandong Province and Yantai City. , build a collaborative research system between laboratories, universities, institutes and pharmaceutical companies to better support the high-quality development of the biomedical industry in Yantai City and Shandong Province.
